School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
Center of Pharmaceutical Outcomes Research (CPOR), Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.
Sci Rep. 2018 Feb 26;8(1):3640. doi: 10.1038/s41598-018-21912-x.
Since licensing in 2006, there has been poor uptake of the HPV vaccine among the targeted population in the South East Asia Region (SEAR) and Western Pacific Region (WPR). A systematic review was conducted to identify the studies exploring the relationship between factors and intention for HPV vaccination among women in SEAR and WPR countries. Nineteen studies were identified as suitable for qualitative synthesis, and three as suitable for meta-analysis. Most women had a positive intention to have an HPV vaccine (range 57%-85%). Having a positive intention to vaccinate was significantly higher among women not aware of HPV infection (OR: 1.34, 95% CI: 1.02-1.76) and HPV vaccine (OR: 1.57, 95% CI: 1.26-1.96). Lower knowledge level and less confidence in safety and efficacy of the vaccine, negatively affected intention to vaccinate. Perceiving the vaccine to be expensive, low perception of contracting HPV infection and cervical cancer, and lack of concrete recommendations from healthcare providers also negatively affected intention to vaccinate. This review suggests the decision-making processes of women in SEAR and WPR is influenced by the cost of vaccination, perceived efficacy and safety of vaccine, provision of information on vaccination, and the awareness about HPV infection and the HPV vaccine.
自 2006 年获得许可以来,东南亚地区(SEAR)和西太平洋地区(WPR)目标人群对 HPV 疫苗的接种率一直很低。进行了系统评价,以确定探索 SEAR 和 WPR 国家女性中与 HPV 疫苗接种意愿相关的因素的研究。确定了 19 项适合定性综合的研究,3 项适合荟萃分析。大多数女性对 HPV 疫苗接种有积极的意愿(范围 57%-85%)。对于不了解 HPV 感染(OR:1.34,95%CI:1.02-1.76)和 HPV 疫苗(OR:1.57,95%CI:1.26-1.96)的女性,接种疫苗的意愿明显更高。知识水平较低、对疫苗安全性和有效性的信心较低,会对接种意愿产生负面影响。认为疫苗昂贵、对 HPV 感染和宫颈癌的认知度低、以及缺乏医疗保健提供者的具体建议,也会对接种意愿产生负面影响。本综述表明,SEAR 和 WPR 地区女性的决策过程受到疫苗接种费用、疫苗的预期疗效和安全性、疫苗接种信息的提供以及对 HPV 感染和 HPV 疫苗的认识的影响。